Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1043 | 983 | 1043 | 1094 | 1072 | 1550 |
Fund Return | 4.27% | -1.74% | 4.27% | 3.03% | 1.41% | 4.48% |
Place in category | 569 | 471 | 569 | 399 | 441 | 300 |
% in Category | 94 | 78 | 94 | 77 | 95 | 86 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UK Equity Income Fund Institutional | 90.88M | 11.88 | 6.34 | 6.64 | ||
UK Equity Income Fund Retail Accumu | 118.6M | 11.26 | 5.76 | 6.04 | ||
UK Equity Income Fund Retail Income | 138.32M | 11.27 | 5.76 | 6.05 | ||
UK Equity Income Fund Z Accumulatio | 671.11M | 12.15 | 6.59 | 6.87 | ||
UK Equity Income Fund Z Income GBP | 645.83M | 12.16 | 6.60 | 6.88 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
VG UK Plus GBP Accumulation | 15.03B | 9.34 | 5.76 | 6.12 | ||
VG UK Institutional Plus GBP Income | 15.03B | 9.34 | 5.75 | 6.11 | ||
Index Unit Trust Accumulation | 15.03B | 9.33 | 5.76 | 6.10 | ||
All Share Index Unit Trust Income | 15.03B | 9.33 | 5.75 | 6.09 | ||
UK Equity Tracker Fund D Acc | 11.63B | 9.28 | 6.08 | 6.28 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.59 | 11,314.0 | +0.73% | |
Shell | GB00BP6MXD84 | 6.55 | 32.01 | +2.93% | |
Unilever | GB00B10RZP78 | 5.41 | 55.72 | +0.91% | |
London Stock Exchange | GB00B0SWJX34 | 3.99 | 12,045.0 | +1.86% | |
Relx | GB00B2B0DG97 | 3.57 | 4,024.00 | +1.36% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review